Abstract
Purpose Tepotinib is a highly selective, potent, mesenchymal-epithelial transition factor (MET) inhibitor, approved for the treatment of non-small cel......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
